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cell antigen recognition involves the formation of a
structured interface between antigen-presenting and
T cells that facilitates the speciﬁc transmission of acti-
vating and desensitizing stimuli. The molecular machinery
that organizes the signaling molecules and controls their
disposition in response to activation remains poorly under-
stood. We show here that in T cells Discs large (Dlg1), a
PDZ domain-containing protein, is recruited upon activation
to cortical actin and forms complexes with early participants
T 
 
in T cell activation. Transient overexpression of Dlg1 atten-
uates basal and Vav1-induced NFAT reporter activation.
Reduction of Dlg1 expression by RNA interference enhances
both CD3- and superantigen-mediated NFAT activation.
Attenuation of antigen receptor signaling appears to be a
complex, highly orchestrated event that involves the mutual
segregation of important elements of the early signaling
complex.
 
Introduction
 
Engagement of the T cell antigen receptor (TCR) during
antigen presentation initiates a sensitive, highly regulated
response that relies on the coordinated action of a large number
of signaling proteins. Recent evidence has shown that exten-
sive rearrangements of membrane and cytoskeletal elements
attend the activation response, and agents that disrupt the
organization or localization of these elements interfere with
antigen recognition (Dustin and Cooper, 2000). Under
certain conditions receptor engagement leads to the assembly
of a characteristic supramolecular activation cluster on the T
lymphocyte side of the interface (Monks et al., 1998).
Molecules that promote and regulate the association of
membrane signaling with the cytoskeleton are expected to
have, at minimum, a mechanism for association with the
signaling molecule and/or membrane, as well as a mechanism
for association with the cytoskeleton. Because such mole-
cules are expected to coordinate the movement and regulation
of large signaling assemblies, they would likely behave as
molecular scaffolds and have mechanisms for interacting
with one another as well as with signaling proteins.
Among candidate molecules with similar functions outside
the immune system, the members of a class of proteins called
PDZ proteins are of particular interest (Montgomery et al.,
2004). The PDZ domains of these proteins form at least two
kinds of protein–protein contact (Songyang et al., 1997).
The best studied is an interaction with the carboxy-terminal
residues of proteins that terminate in a variably conserved se-
quence of form S/T-X-V or Y/F-X-V although considerable
latitude is observed. PDZ domains also appear to be able to
interact with internal residues on some proteins, including
PDZ domains themselves. Thus, the PDZ domain itself has
the attributes expected of a scaffolding structure supporting
heterotypic and homotypic interactions.
Recent studies have described a role for membrane-
associated guanylate kinases (MAGUKs) in T cell activa-
tion. Compromise of expression of the MAGUK protein,
CARMA-1, by germline targeting, somatic mutation, or
RNA interference inhibits antigen receptor mediated NF-
 
 
 
B
activation (Jun and Goodnow, 2003; Thome, 2004).
The human homologue of 
 
Drosophila
 
 Discs large (Dlg1) is
a MAGUK found in postsynaptic densities in the central
nervous system (Muller et al., 1995). Dlg1 has been impli-
cated in the formation of tight junctions, in epithelial cell
polarity, and in the control of proliferation of 
 
Drosophila
 
imaginal discs. It consists of an amino-terminal proline-rich
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domain, multiple PDZ domains, an SH3 domain, HOOK
domain, i3 domain, and a guanylate kinase (GK)–like
domain.
We present evidence that Dlg1 localizes with the actin cy-
toskeleton in T cells, associates with early participants in the
signaling process and functions as a negative regulator of T
cell activation.
 
Results and discussion
 
To explore the possible roles of PDZ proteins in T cell acti-
vation, we conducted a survey of expression in the Jurkat T
cell line, focusing on proteins that might associate with lipid
rafts, plasma membrane, or signaling intermediates. Dlg1 is
expressed throughout all T cell developmental stages and in
previous studies has been shown to form a stable complex
with the Src family kinase Lck. (Hanada et al., 1997).
The i3 domain of Dlg1 is thought to interact with ezrin-
radixin-moesin family proteins, which couple membrane
proteins to the actin skeleton (Lue et al., 1996; Wu et al.,
1998); in T cells ezrin associates with the immunological
synapse (Roumier et al., 2001). We analyzed the distribu-
tion of actin and Dlg1 in Jurkat cells allowed to settle on
coverslips coated with anti-CD3 antibody OKT3 (Bunnell
et al., 2001). As described previously (Bunnell et al., 2001),
dramatic reorganization of the cellular architecture follows
contact with the OKT3-coated surface, with prominent
emergence of microspikes, filopodia, and lamellipodia. Fig.
1 A demonstrates that 2 min after contact endogenous Dlg1
was predominantly cytosolic, but by 5 min it had become
codistributed with the cortical actin and lamellipodial struc-
tures. A more prominent concentric band of cortical actin
was induced in Jurkat cells on adhering to immobilized anti-
CD3 and anti-CD28.
Activation of T cells by anti-CD3 and anti-CD28 beads is
a related, well-validated system for studying the large-scale
reorganization of cellular constituents after exposure to ago-
nistic stimuli (Roumier et al., 2001). As shown in Fig. 1 B,
upon contact with CD3/CD28-antibody–coated beads, en-
dogenous Dlg1 is redistributed to membrane caps and ex-
tensively colocalizes with actin. Recruitment of Dlg1 to the
bead–cell interface is transient: 15 min after stimulation,
Dlg1 is no longer enriched at the contact zone (Fig. 1 C). In
contrast, CD19-coated beads do not have a significant effect
on Dlg1 localization to the bead–cell interface (Fig. 1 B).
To study recruitment of Dlg1 to the T cell antigen-pre-
senting cell (APC) interface we performed immunolocaliza-
tion studies (Roumier et al., 2001; Lee et al., 2002) after
stimulation with superantigen or antigenic peptide. Jurkat
cells were incubated with Raji cells pulsed with staphylococ-
cal enterotoxin E (SEE) and the distribution of actin and
Dlg1 was analyzed by immunofluorescence microscopy. In
the absence of SEE, Dlg1 and actin were evenly distributed
in Jurkat cells, whereas in the presence of SEE, Dlg1 and ac-
tin were concentrated at the cell contact interface at 5 and
10 min (Fig. 2 A; not depicted). Within 5 min of exposure
to SEE, TCR
 
 
 
 can be seen to translocate to the contact zone
and colocalize with Dlg1 (Fig. 2 B). Dlg1 colocalization at
the Raji–Jurkat interface was seen to diminish after pro-
longed association of the presenting and responding cells.
We next examined if Dlg1 was recruited to the immune
synapse when antigen-loaded B cells (prepared as LPS-elic-
Figure 1. Dlg1 associates with mem-
brane actin after receptor engagement 
in T cells and relocalizes after T cell 
receptor activation by antibody-
conjugated beads. (A). Jurkat cells were 
allowed to settle in complete medium 
on coverslips coated with polylysine, 
anti-CD3 antibody, or anti-CD3 plus 
anti-CD28 antibodies. Cells were fixed 
and permeabilized and stained with 
phallotoxin conjugated with Alexa 
Fluor 594 (for visualization of actin) and 
polyclonal rabbit anti-Dlg1. (B) Images 
acquired 5 min after exposure of cells 
to beads bearing anti-CD3 and anti-
CD28 antibody. Dlg1 and actin were 
visualized with anti-Dlg1 antibody and 
fluorescent phallotoxin, respectively. 
Dlg1 does not localize at the contact 
region between Jurkat cells and beads 
conjugated with anti-CD19 antibody. 
(C) Images acquired 15 min after exposure 
of cells to beads bearing anti-CD3 and 
anti-CD28 antibody. Four representative 
images demonstrate the redistribution 
of endogenous Dlg1 away from the 
contact surface. 
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ited blast cells) were incubated with MHC-matched splenic
T cells obtained from DO11.10 TCR transgenic mice bear-
ing T cell receptors specific for the peptide antigen. In this
system Dlg1 was recruited transiently to the immune syn-
apse at 5 min (Fig. 2 C). Dlg1 was also detected in the LPS
blasts and B cell lines and has been described in B lympho-
cytes (Lue et al., 1994). Using quantitative PCR we have
shown that Dlg1 expression is regulated in B cell subsets
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200309044/DC1).
To better understand the association patterns of Dlg1
with other molecules, we immunoprecipitated Dlg1 from
the cytosolic and membrane fractions of Jurkat T cells that
had been exposed to agonistic antibody (anti-CD3 and anti-
CD28) stimulation. We first confirmed that Dlg1 specifi-
Figure 2. APC-T cell activation induces Dlg1 relocalization. (A) Dlg1 accumulates at the T cell–B cell contact site. Jurkat cells were incubated 
with Raji cells that had been exposed to medium with or without SEE for 5, 10, 15, and 20 min. Raji cells were labeled with CMAC cell 
tracker blue. F-actin and Dlg1 accumulation were induced by SEE pulsed Raji cells at 5 and 10 min (not depicted). Representative images 
show no increase in Dlg1 accumulation at cell–cell contact site at 20 min. (B) Codistribution of CD3  and Dlg1 after activation of Jurkat cells 
with Raji cells loaded with SEE. CD3  and Dlg1 colocalize at the cell–cell contact site at early time points (5 min) after activation. Raji
cells are labeled with CMAC tracker blue (CT blue). (C) Dlg1 localizes transiently at the immune synapse after antigenic stimulation of
T cells. LPS-activated B cells (labeled blue) were pulsed with ova-peptide and mixed with DO11.10 transgenic T cells. F-actin and Dlg1 
were recruited to the contact area at 5 min.
 
Figure 3.
 
Proteins coordinated by Dlg1.
 
 (A) Multiple signaling 
molecules associate with Dlg1 in T cells. Membrane and cytosolic 
fractions from unstimulated and anti-CD3 plus CD28-stimulated 
Jurkat cells were immunoprecipitated with Dlg1 antibody, resolved 
by SDS-PAGE and immunoblotted with antibodies recognizing the 
proteins shown. TL represents 10 
 
 
 
l of non-immunoprecipitated 
total lysate loaded with each blot to confirm antibody specificity. 
Iso represents the result of immunoblotting lysates prepared by 
immunoprecipitation with an isotype-matched control antibody. 
(B) Phospho-
 
 
 
 (p23
 
 
 
) association with Dlg1. Dlg1 immunoprecipitates 
from cytosol, membrane fractions, and nucleus fractions were probed 
with anti-TCR
 
 
 
 (left) or with anti-phosphotyrosine antibody 4G10 
(right). The top bands in the immunoblots represent immunoglobulin 
light chain. White lines indicate that intervening lanes have been 
spliced out. 
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cally interacts with Lck in Jurkat cells (Hanada et al., 1997).
We next showed that endogenous Dlg1 specifically affiliates
with the signaling molecules TCR
 
 
 
 and Cbl. The TCR
 
 
 
species complexed with Dlg1 contains both phosphorylated
and nonphosphorylated components, and the phosphoryla-
tion status depends on the activities of Lck and Zap-70 (Fig.
3, A and B; not depicted).
Overexpression of Vav1 has been shown to enhance CD3-
dependent NFAT reporter activation (Wu et al., 1995). As
demonstrated in Fig. 4 (A and B), coexpression of Dlg1 and
Vav1 inhibits Vav1-induced basal and CD3-potentiated
NFAT activity. A carboxy-terminal Dlg1 fragment that con-
tains the PDZ3-SH3-I3-GK domains enhanced NFAT ac-
tivity in this system. Coexpression of Dlg1 with Vav1 atten-
uated NFAT reporter activity in Jurkat cells stimulated by
SEE-loaded Raji cells (Fig. 4 C).
Suppression of endogenous gene expression by short
hairpin RNA (shRNA) has been used to create hypomor-
phic phenotypes in mammalian cells (Brummelkamp et al.,
2002). We created shRNAs targeted to Dlg1 sequences in
the SH3 (shRNA #1) and GK domains (shRNA#2). Lysates
from pooled stable transfectants expressing shRNA were
blotted with an anti-Dlg1 antibody. As shown in Fig. 5 A,
shRNA#2 gave significant suppression of expression. Fig. 5
B shows that Dlg1 suppression caused an increase in basal
NFAT activity and a potentiation of the response to anti-
CD3 stimulation. We found similar effects on NFAT re-
porter activity after stable and transient transfection of
shRNA in Jurkat cells (not depicted). To determine if Dlg1
knockdown had a similar effect on superantigen-mediated
NFAT activation, Jurkat cells expressing shRNAs against the
SH3 and GK domains were activated with SEE pulsed Raji
B cells. As shown in Fig. 5 C, RNA interference of Dlg1 en-
hanced superantigen-mediated NFAT activation.
In subcellular fractionation studies we have demonstrated
that Dlg1 complex in T cells contains Lck, TCR
 
 
 
, and Cbl
and colocalization studies lend support for these biochemical
observations (unpublished data). In neuronal synaptic sig-
naling and 
 
Drosophila
 
 embryogenesis Dlg1 associates with a
subset of AMPA receptors, Kv channels, and membrane pro-
teins on endomembranes and appears to regulate the abun-
dance of these proteins at the plasma membranes (Tiffany et
al., 2000; Lee et al., 2003). Dlg1 has been shown to associ-
ate with AKAP-79 in hippocampal neurons (Colledge et al.,
2000), and AKAP-79 interactions with calcineurin and pro-
tein kinase A are known to inhibit NFAT activation (Kash-
ishian et al., 1998; Crabtree and Olson, 2002). Additional
studies will be required to determine if Dlg1 plays a similar
role in delivery of components of the TCR signal complex to
the plasma membrane during lymphocyte differentiation
and activation. Dlg1 may also play a role in signaling via the
BCR as well.
The interpretation that Dlg1 acts as an activation antago-
nist is consistent with findings from other systems. The
phenotype that originally led to the discovery of Dlg1,
grossly enlarged imaginal disks in 
 
Drosophila
 
, suggested a
role for the protein in restraint of imaginal disk cell prolifer-
ation, and Dlg1 has been considered to be a kind of tumor
suppressor in 
 
Drosophila
 
 (Dimitratos et al., 1999). The con-
nection with the cortical actin skeleton suggests that one
Figure 4. Effects of Dlg1 expression on transcrip-
tional activity in Jurkat cells. (A) Overexpression 
of Dlg1 attenuates Vav1-induced NFAT transcrip-
tional activity. NFAT activity was measured after 
cotransfection of Jurkat cells with the indicated 
plasmids and an NFAT-luciferase reporter construct. 
After stimulation, cells were lysed and luciferase 
activity was measured. Relative activity is corrected 
for transfection efficiency. (Bottom) Immunoblot 
analysis confirms expression of constructs used 
in the reporter assay. (B) Effects of Dlg1 on Vav1 
basal and anti-CD3 stimulated NFAT activation in 
Jurkat cells. Overexpression of Dlg1 inhibits Vav1 
induction of NFAT activity, whereas overexpression 
of Dlg1 carboxy-terminal fragment potentiates 
the Vav1 effect. (Bottom) Immunoblot illustrates 
relative expression of various constructs used in 
reporter assay. (C) Overexpression of Dlg1 suppresses 
NFAT activation by coexpressed Vav1 in Jurkat 
cells stimulated by superantigen pulsed Raji cells. 
Jurkat T cells were transfected with NFAT-luciferase 
reporter, Vav1 and Dlg1 constructs. 20 h after 
transfection, cells were stimulated with Raji cells 
pulsed with SEE for 8 h and lysed for luciferase 
assay. (Bottom) Immunoblot analysis confirms 
expression of constructs used in the reporter assay. 
White lines indicate that intervening lanes have 
been spliced out. Error bars represent SEM. 
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important role of Dlg1 may be to promote receptor inter-
nalization and/or recycling after the initial phase of contact
and engagement.
 
Materials and methods
 
Reagents
 
The 10.10.4 Jurkat subclone used in this work has been engineered to ex-
press SV40 large T antigen and inducible cell surface proteins, and se-
lected for high (
 
 
 
90%) expression of CD3. Antibodies obtained include:
Cbl, PKC-
 
 
 
, CD45 (Transduction Laboratories); actin (ICN Biomedicals);
chapsyn (Calbiochem); CD3
 
 
 
 (BD Biosciences); Dlg1, TCR
 
 
 
 (Santa Cruz
Biotechnology, Inc.); GADS, Lck, Zap-70, Vav-1 (Upstate Biotechnology);
CD3
 
 
 
 (Zymed Laboratories); and SAP97 rabbit polyclonal antibody for im-
munostaining experiments was provided by M. Sheng (Massachusetts Insti-
tute of Technology, Cambridge, MA).
 
Expression constructs
 
Construction of rat Dlg1-GFP and deletion constructs have been described
(as SAP97-GFP) elsewhere (Wu et al., 1998). These constructs were pro-
vided by C. Garner (Stanford University, Palo Alto, CA). For reporter assays
carboxy-terminal GFP tag sequences were introduced in-frame with full-
length SAP97 and carboxy-terminal deletion constructs consisting of resi-
dues, 1–909, 219–906 (PDZ2-3-SH3-I3-GK), 406–906 (PDZ3-SH3-I3-GK),
and 540–906 (SH3-I3-GK). Human Dlg1 was isolated by PCR amplification
from a Raji cell library and inserted between HindIII and NotI sites down-
stream of an EF1
 
 
 
 promoter.
 
Immunoprecipitations
 
10
 
7
 
 Jurkat cells were stimulated with 2 
 
 
 
g/ml of anti-CD3 antibody (OKT3)
and 2 
 
 
 
g/ml of anti-CD28 (clone 9.3), washed twice in 1-ml of ice cold
PBS and resuspended in 750 
 
 
 
l of hypotonic lysis buffer (20 mM Tris HCl,
pH 7.5, 10 mM NaCl, 2 mM EDTA, 5 mM EGTA, 10 mM 
 
 
 
-ME, one pro-
tease inhibitor cocktail tablet (Roche) per 10 ml, 1 mM Na
 
3
 
VO
 
4
 
, 20 mM
NaF), transferred to a 1-ml syringe, and sheared by passing 30 times
through a 25-gauge needle. The lysates were centrifuged at 1,000 rpm for
7 min to precipitate nuclei and the supernatant was collected. 50 
 
 
 
l of the
total cell extract was saved, and the remainder was centrifuged at 16,000
rpm for 20 min. The supernatant was collected and the pellet resuspended
in lysis buffer with 1% NP-40 for 30 min with gentle vortexing every 5 min
on ice. The supernatant and membrane fractions were immunoprecipi-
tated for 4 h at 4
 
 
 
C with Dlg1 (Santa Cruz Biotechnology, Inc.) specific an-
tisera. Isotype controls were performed for each immunoprecipitation. Im-
mune complexes were collected with goat anti–mouse beads (Amersham
Biosciences) and washed three times with lysis buffer. Bound proteins
were eluted with 50 
 
 
 
l SDS sample buffer and resolved by SDS-PAGE.
Proteins were transferred to PVDF membranes, which were blocked over-
night and probed with indicated antibody. After washing, filters were incu-
bated with a 1:5,000 dilution of anti–mouse or anti–rabbit HRP conjugate
(DakoCytomation) in TBST for 1 h. Protein bands were detected by ECL
(Amersham Biosciences).
 
Luciferase assays
 
Determination of NFAT activities was performed as described previously
(Wu et al., 1995; Roumier et al., 2001). In brief, 5 
 
 
 
 10
 
6
 
 Jurkat cells were
sedimented, resuspended in 0.25 ml IMDM, and electroporated (250
V/960 
 
 
 
F) with 10 
 
 
 
g of NFATx3-luciferase reporter construct, 10 
 
 
 
g of
full-length or fragments of Dlg1-GFP or1 
 
 
 
g pcDNA3-Vav1, and 1 
 
 
 
g
pEAK12-GFP. Upon electroporation, cells were diluted in 2 ml IMDM,
placed in wells of a 6-well plate, and incubated for 16 h. 0.5-ml aliquots
were then transferred to wells of a 24-well plate and exposed to 5 
 
 
 
g/ml
OKT3. Alternatively, Raji cells pulsed with SEE for 30 min were incubated
with T cells overexpressing or knockdown of Dlg1 for 6 h at 37
 
 
 
C. Lucifer-
ase assays were performed according to the manufacturer’s instructions
(Promega). The electroporation efficiency was normalized by assessing
GFP expression by flow cytometry. Expression of various constructs was
confirmed by immunoblots.
 
RNA interference
 
The vector pSuppress consisting of the RNA polymerase III–dependent H1-
RNA gene promoter was provided by D. Billadeau (Division of Oncology
Research, Mayo Clinic, Rochester, MN). Complementary oligonucleotides
designed against sequences in the SH3 domain shRNA#1 (5
 
 
 
-GATC-
CCCgactaaagacagtgggcttTTCAAGAGAaagcccactgtctttagtcTTTTTGGAAA-3
 
 
 
and 5
 
 
 
-TCGATTTCCAAAAAgactaaagacagtgggcttTCTCTTGAAaagcccact-
gtctttagtcGGG-3
 
 
 
) and shRNA#2 designed against sequences in the GK do-
main (5
 
 
 
-GATCCCCgagagcagatggaaaaagaTTCAAGAGAtctttttccatctgctctc-
TTTTTGGAAA-3
 
 
 
 and 5
 
 
 
-TCGATTTCCAAAAAgagagcagatggaaaaagaTCT-
CTTGAAtctttttccatctgctctcGGG-3
 
 
 
) were cloned into unique BglII–XhoI site
downstream of HI RNA promoter and inserts were confirmed by sequenc-
ing. Stable Jurkat cells were generated by transfecting shRNA expressing
vector: pEAK12-GFP puromycin plasmid at 10:1 ratio. Stables were ex-
panded for an additional 4 wk before immunoblot analysis for Dlg1 expres-
sion and NFAT reporter analysis. Reporter analysis was performed as de-
scribed above.
 
Fluorescence microscopy
 
Jurkat T cells were stimulated with anti-CD3 antibody (OKT3) on cover-
slips as described previously (Bunnell et al., 2001). Coverslips were coated
with 10 
 
 
 
g/ml anti-CD3 antibody and 10 
 
 
 
g/ml anti-CD28 for 2 h at 37
 
 
 
C
in a moist chamber. The slides were washed with PBS four times. Spread-
ing assays were initiated by placing 10 
 
 
 
l of a concentrated Jurkat cell sus-
pension on anti-CD3–coated coverslips. After incubation at 37
 
 
 
C for 2 or 5
min, the cells were fixed for 10 min with 3.5% PFA and 0.1% Tween-20 in
PBS at RT.
Jurkat T cells were stimulated with antibody-coated beads and APCs
(Raji cells) pulsed with SEE as described previously (Roumier et al., 2001).
In brief, the cells were mixed with beads coated with CD3/CD28 (Dynal)
at a ratio of two beads/cell. After centrifugation for 5 min at 100 g, the
cell–bead mixture was incubated for an additional 5–15 min at 37
 
 
 
C. Con-
jugates were then resuspended, plated onto poly-
 
L
 
-lysine–coated slides,
Figure 5. Stable RNA interference of Dlg1 in Jurkat cells enhances 
NFAT activity. (A) Cells expressing shRNA were lysed in 1% Triton 
X-100 buffer and an equal amount protein from each cell line was 
resolved on a 7.5% SDS gel and blotted with antibodies recognizing 
Dlg1, actin, GSK, and Lck. (B) Activation of NFAT luciferase reporter 
in Jurkat cells stably transfected to express shRNA targeted against 
the Dlg1 SH3 domain (shRNA1) or GK domain (shRNA2). Cells 
were transfected with NFAT-luciferase reporter. 24 h after transfection, 
cells were stimulated with anti-CD3 (5  g/ml) for 8 h and lysed 
for assay. (C) Activation of NFAT luciferase reporter in Jurkat cells 
stably transfected to express shRNA targeted against the Dlg1 SH3 
domain (shRNA1) or GK domain (shRNA2). Pooled stable cells 
were transfected with NFAT-luciferase reporter construct. 20 h after 
transfection, cells were stimulated with Raji cells pulsed with SEE 
for 8 h and lysed for luciferase assay. (Bottom) Immunoblot analysis 
confirms shRNA suppression of Dlg1 expression. White lines indicate 
that intervening lanes have been spliced out. Error bars represent SEM. 
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and fixed for 10 min as above. To distinguish APCs from Jurkat cells, APCs
were loaded with cell tracker CMAC blue (CT blue – molecular probes).
T cells were obtained from DO11.10 transgenic mice as described pre-
viously (Lee et al., 2002). DO11.10 transgenic T cells were induced with
OVA peptide in bulk splenocyte cultures for 5–6 d, washed extensively
and spun over Lympholyte M to remove dead cells and debris. T cells were
rested in media supplemented with IL2 for several hours or overnight. To
initiate conjugate formation, T cells were centrifuged briefly with LPS-
induced B cell blasts (used as APCs) pulsed with 1–10 
 
 
 
M OVA peptide
for 2–3 h at 37
 
 
 
C and incubated for 1, 2, 5, or 10 min. Conjugates were ex-
amined for endogenous Dlg1 recruitment to the immune synapse by im-
munofluorescence microscopy.
After blocking with PBS including 1% BSA, the cells were labeled with
rabbit anti-Dlg1, mouse anti-CD3 antibody in PBS including 1% BSA, fol-
lowed by three washes of 5 min each. After labeling with secondary anti-
body conjugated with Alexa Fluor 488 (Molecular Probes), phallotoxin
conjugated with Alexa Fluor 594 (Molecular Probes) and DAPI, the slides
were mounted with Aqua Poly/Mount (Polyscience). F-actin polymeriza-
tion was analyzed by immunofluorescence microscopy using an Axio-
scope (Carl Zeiss MicroImaging, Inc.) microscope, with focus adjusted to
the plane of maximum staining intensity. More than 100 cells were ana-
lyzed for each condition (either resting or after TCR activation).
 
Online supplemental material
 
Fig. S1 is an analysis of Dlg1 expression in B cell developmental subsets by
real-time PCR. Online supplemental material is available at http://www.
jcb.org/cgi/content/full/jcb.200309044/DC1.
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